Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial
- DOI
- 10.1016/s2468-1253(24)00387-x
- Published
- 2025-03
- Container
- The Lancet Gastroenterology & Hepatology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s2468-1253-24-00387-x,
title = {Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial},
author = {John W K Chia and Eva Segelov and Yanhong Deng and Gwo Fuang Ho and Wei Wang and Shuting Han and Atul Sharma and Kefeng Ding and Gong Chen and Mark G Jeffery and Chee Kian Tham and Joong Bae Ahn and Louise Nott and Robert Zielinski and Tsu-Yi Chao and Tom van Hagen and Po-Li Wei and Fiona Day and Shaesta Mehta and Thomas Yau and Jiewen Peng and Theresa M Hayes and Yong Li and Mihir Gandhi and Estelle M J Foo and Nabilah Rahman and Peter Rothwell and Raghib Ali and John Simes and Han Chong Toh},
year = {2025},
journal = {The Lancet Gastroenterology \& Hepatology},
doi = {10.1016/s2468-1253(24)00387-x},
url = {https://doi.org/10.1016/s2468-1253(24)00387-x}
}RIS
TY - JOUR TI - Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial AU - John W K Chia AU - Eva Segelov AU - Yanhong Deng AU - Gwo Fuang Ho AU - Wei Wang AU - Shuting Han AU - Atul Sharma AU - Kefeng Ding AU - Gong Chen AU - Mark G Jeffery AU - Chee Kian Tham AU - Joong Bae Ahn AU - Louise Nott AU - Robert Zielinski AU - Tsu-Yi Chao AU - Tom van Hagen AU - Po-Li Wei AU - Fiona Day AU - Shaesta Mehta AU - Thomas Yau AU - Jiewen Peng AU - Theresa M Hayes AU - Yong Li AU - Mihir Gandhi AU - Estelle M J Foo AU - Nabilah Rahman AU - Peter Rothwell AU - Raghib Ali AU - John Simes AU - Han Chong Toh PY - 2025 JO - The Lancet Gastroenterology & Hepatology DO - 10.1016/s2468-1253(24)00387-x UR - https://doi.org/10.1016/s2468-1253(24)00387-x ER -
APA
Chia, J. W. K., Segelov, E., Deng, Y., Ho, G. F., Wang, W., Han, S., Sharma, A., Ding, K., Chen, G., Jeffery, M. G., Tham, C. K., Ahn, J. B., Nott, L., Zielinski, R., Chao, T., Hagen, T. V., Wei, P., Day, F., Mehta, S., Yau, T., Peng, J., Hayes, T. M., Li, Y., Gandhi, M., Foo, E. M. J., Rahman, N., Rothwell, P., Ali, R., Simes, J., & Toh, H. C. (2025). Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(24)00387-x
Source records
- crossref · retrieved 2026-09-26T10:20:20.642Z